FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA - CURRENT TRENDS IN DIAGNOSIS AND THERAPY

被引：46

作者：

KAPLAN, C

MORELKOPP, MC

CLEMENCEAU, S

DAFFOS, F

FORESTIER, F

TCHERNIA, G

机构：

[1] INST PUERICULTURE, F-75014 PARIS, FRANCE

[2] HOP BICETRE, HEMATOL LAB, F-94270 LE KREMLIN BICETRE, FRANCE

来源：

TRANSFUSION MEDICINE | 1992年 / 2卷 / 04期

关键词：

ALLOIMMUNE; DIAGNOSIS; FETAL; NEONATAL; THERAPY; THROMBOCYTOPENIA;

D O I：

10.1111/j.1365-3148.1992.tb00168.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Neonatal thrombocytopenia affects 20-40% of the infants in intensive care units. The frequency of neonatal alloimmune thrombocytopenia (NAIT) is estimated at 1/1500 to 1/5000 live births. The risk of morbidity is significant with 20% neurological sequelae and the death rate is estimated at 10% of affected infants. During recent years considerable efforts have been made to prevent fetal bleeding and to avoid birth trauma, which have significantly changed the natural history of NAIT.

引用

页码：265 / 271

页数：7

共 56 条

[1] NEONATAL ALLOIMMUNE AMEGAKARYOCYTOSIS - CASE-REPORT [J].